Isa Odidi
Chief Executive Officer bei INTELLIPHARMACEUTICS INTERNATIONAL INC.
Vermögen: - $ am 30.04.2024
Profil
Isa Odidi is the founder of Intellipharmaceutics International, Inc., which was founded in 1998.
He is currently the Chairman of Smart Pharmaceutical Shanghai Ltd.
and a Professor at Toronto Institute of Pharmaceutical Technology.
In the past, he served as the Chief Executive Officer of IntelliPharmaCeutics Ltd.
and as the VP-Drug Development & New Technologies Research at Biovail Corp.
from 1995 to 1998.
Dr. Odidi has an MBA from Rotman School of Management, graduate and doctorate degrees from the University of London, and an undergraduate degree from Ahmadu Bello University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.02.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Isa Odidi
| Unternehmen | Position | Beginn |
|---|---|---|
| INTELLIPHARMACEUTICS INTERNATIONAL INC. | Chief Executive Officer | 01.01.1998 |
| Toronto Institute of Pharmaceutical Technology | Corporate Officer/Principal | - |
| Smart Pharmaceutical Shanghai Ltd. | Chairman | - |
Ehemalige bekannte Positionen von Isa Odidi
| Unternehmen | Position | Ende |
|---|---|---|
IntelliPharmaCeutics Ltd.
 IntelliPharmaCeutics Ltd. Pharmaceuticals: MajorHealth Technology IntelliPharmaCeutics Ltd. designs and develops controlled release drugs. The firm engages in research, development, licensing & marketing of new and generic controlled release pharmaceutical products. It provides life cycle management or new chemical entity delivery system solutions for small molecule drugs through its patented HYPERMATRIX technology. It was founded in 1998 and is headquartered in Toronto, Canada. | President | 27.10.2009 |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01.01.1998 |
Ausbildung von Isa Odidi
| Rotman School of Management | Masters Business Admin |
| University of London | Doctorate Degree |
| Ahmadu Bello University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTELLIPHARMACEUTICS INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
IntelliPharmaCeutics Ltd.
IntelliPharmaCeutics Ltd. Pharmaceuticals: MajorHealth Technology IntelliPharmaCeutics Ltd. designs and develops controlled release drugs. The firm engages in research, development, licensing & marketing of new and generic controlled release pharmaceutical products. It provides life cycle management or new chemical entity delivery system solutions for small molecule drugs through its patented HYPERMATRIX technology. It was founded in 1998 and is headquartered in Toronto, Canada. | Health Technology |
| Smart Pharmaceutical Shanghai Ltd. |
